Oligonucleotide Encoded Chemical Libraries (2018)

Plexium, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 62/562,905, filed Sep 25, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 10,946,383	Oligonucleotide Encoded Chemical Libraries Plexium, Inc. In force Term ends Sep 24, 2038 · High confidence	Plexium, Inc.	In force	Term ends Sep 24, 2038	Term ends Sep 24, 2038	High confidence
US 12,030,057	Oligonucleotide Encoded Chemical Libraries Plexium, Inc. In force Ends no later than Sep 24, 2038 · Medium confidence	Plexium, Inc.	In force	Ends no later than Sep 24, 2038	Ends no later than Sep 24, 2038	Medium confidence
US 11,577,249	Oligonucleotide Encoded Chemical Libraries Plexium, Inc. In force Term ends Oct 11, 2038 · High confidence	Plexium, Inc.	In force	Term ends Oct 11, 2038	Term ends Oct 11, 2038	High confidence
US 11,084,037	Oligonucleotide Encoded Chemical Libraries Plexium, Inc. In force Term ends Aug 31, 2039 · High confidence	Plexium, Inc.	In force	Term ends Aug 31, 2039	Term ends Aug 31, 2039	High confidence

4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.